Exploring the controversy over the name(s) to use when describing Fatty Liver disease(s)
Professor Quentin Anstee joins the Surfers for a thoughtful consideration of the factors that should drive the decision on what name(s) to use for different Fatty Liver diseases. The group considers a range of issues from our level of scientific knowledge to the semiotics of naming to how patients react to certain disease descriptions, all in a stimulating, freewheeling discussion.